Financhill
Back

AnaptysBio Quote, Financials, Valuation and Earnings

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Sell
2

ANAB
AnaptysBio

Last Price:
19.91
Seasonality Move:
1.79%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

AnaptysBio Price Quote

$19.91
+0.03 (+-0.15%)
(Updated: November 6, 2024 at 4:58 AM ET)

AnaptysBio Key Stats

Sell
2
AnaptysBio (ANAB) is a Sell

Day range:
$19.00 - $19.93
52-week range:
$13.36 - $41.31
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
17.50
P/B ratio:
55.24%

Volume:
442.8K
Avg. volume:
450K
1-year change:
13.41%
Market cap:
$545.7M
Revenue:
$17.2M
EPS:
$-6.35

How Much Does AnaptysBio Make?

  • How Much Are AnaptysBio's Sales Annually?
    ANAB Revenues are $17.2M
  • How Much Profit Does AnaptysBio's Make A Year?
    ANAB net income is -$163.6M

Is AnaptysBio Growing As A Company?

  • What Is AnaptysBio's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 2.17%
  • What Is AnaptysBio's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

AnaptysBio Stock Price Performance

  • Did AnaptysBio Stock Go Up Last Month?
    AnaptysBio share price went down by -41.5% last month
  • Did ANAB's Share Price Rise Over The Last Year?
    ANAB share price rose by 13.41% over the past 1 year

What Is AnaptysBio 52-Week High & Low?

  • What Is AnaptysBio’s 52-Week High Share Price?
    AnaptysBio has traded as high as $41.31 over the past 52 weeks
  • What Is AnaptysBio’s 52-Week Low Share Price?
    AnaptysBio has traded as low as $13.36 over the past 52 weeks

AnaptysBio Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy AnaptysBio?

  • How Much Debt Does AnaptysBio Have?
    Total long term debt quarterly is $0
  • How Much Cash Does AnaptysBio Have?
    Cash and short term investments quarterly total is $350.8M
  • What Is AnaptysBio’s Book Value Per Share?
    Book value per share is 0.36

Is AnaptysBio Cash Flow Positive?

  • What Is ANAB Cash Flow From Operations?
    Cash flow from operations (TTM) is -$129.4M
  • What Is AnaptysBio’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $20M
  • What Is AnaptysBio’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $146M

AnaptysBio Return On Invested Capital

  • Is Management Doing A Good Job?
    ANAB return on invested capital is -205.16%
  • What Is AnaptysBio Return On Assets?
    ROA measures how assets are converting to revenues and is -37.14%
  • What Is ANAB Return On Equity?
    ROE is a measure of profitability and is -205.16%

AnaptysBio Earnings Date & Stock Price

  • What Is AnaptysBio's Stock Price Today?
    A single share of ANAB can be purchased today for 19.88
  • What Is AnaptysBio’s Stock Symbol?
    AnaptysBio trades on the nasdaq under the ticker symbol: ANAB
  • When Is AnaptysBio’s Next Earnings Date?
    The next quarterly earnings date for AnaptysBio is scheduled on November 8, 2024
  • When Is ANAB's next ex-dividend date?
    AnaptysBio's next ex-dividend date is November 6, 2024
  • How To Buy AnaptysBio Stock?
    You can buy AnaptysBio shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

AnaptysBio Competitors

  • Who Are AnaptysBio's Competitors?
    Below is a list of companies who compete with AnaptysBio or are related in some way:
    • ADMA Biologics Inc (ADMA)
    • Agios Pharmaceuticals Inc (AGIO)
    • Black Diamond Therapeutics Inc (BDTX)
    • Ligand Pharmaceuticals Inc (LGND)
    • Regeneron Pharmaceuticals Inc (REGN)

AnaptysBio Dividend Yield

  • What Is ANAB Dividend Yield?
    AnaptysBio’s dividend yield currently is 0%
  • What Is AnaptysBio’s Payout Ratio?
    AnaptysBio’s payout ratio is 0%
  • When Did AnaptysBio Last Pay A Dividend?
    The latest dividend pay date is November 6, 2024
  • What Is AnaptysBio’s Dividend Per Share?
    AnaptysBio pays a dividend of $0.00 per share

AnaptysBio Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -83.48%
Revenue: 217.08% -51.79%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 55.64
Upside from Last Price: 179.86%

Major Shareholders

  • How many ANAB shares are owned by institutional investors?
    42M ANAB shares are owned by institutional investors
  • How many ANAB shares are owned by insiders?
    1M ANAB shares are owned by insiders